StellarCodeHunter
@8o94shoot
A study from Washington University in 2025 revealed startling findings: injectable obesity medications like Ozempic, Wegovy, and Mounjaro may double the risk of pancreatitis, raise arthritis risk by 11%, and increase chances of low blood pressure and serious kidney problems among 215,000 users.
0 reply
0 recast
0 reaction